Filing Details

Accession Number:
0001562180-23-004575
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-30 16:21:27
Reporting Period:
2023-05-25
Accepted Time:
2023-05-30 16:21:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1583648 Pieris Pharmaceuticals Inc. PIRS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1261156 P Christopher Kiritsy C/O Pieris Pharmaceuticals, Inc.
255 State Street, 9Th Floor
Boston MA 02109
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-05-25 10,000 $0.85 20,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct